| Nanning Huiyou Xingyao Equity Investment Fund L.P. |
| Main Business: |
Biopharmaceutical investment (for an investment in Wuhan YZY Biopharma Co., Ltd.) |
| Headquarters: |
Nanning, Guangxi |
| Type of Company: |
Limited partnership |
| Date of Investment: |
November 2020 |
| Investment Cost: |
US$3.66 million (31/12/2024) |
| Company's Interest: |
21.24% (31/12/2024) |
 |
|
| Immvira Bioscience Inc. |
| Main Business: |
Biotech research and development |
| Headquarters: |
Shenzhen, Guangdong |
| Type of Company: |
Limited liability company |
| Date of Investment: |
October 2022 |
| Investment Cost: |
US$8 million (31/12/2024) |
| Company's Interest: |
1.65% (31/12/2024) |
|
|
|
